Dr Petracek to lecture at Pre-Marketing Clinical Safety DIA Course in London
May 11, 2015
Dr Jan Petracek, PharmInvent CEO, and his esteemed colleague Michael Forstner PhD will lecture together for a course in Pre-Marketing Clinical Safety to be held in London May 18th and 19th 2015.
This intensive course is especially designed for professionals involved in the management of safety information for clinical trials in the EU. Participants will be exposed to all the regulations and guidelines pertinent to pre-marketing safety in the EU. The course will include topics such management of adverse events, strategies for un-blinding, SUSAR reporting, compilation of DSURs, the EudraVigilance CT module, risk assessment in clinical trials and safety risk management.
For more information please go to DIA website.
- Pre-Marketing Clinical Safety Programme (PDF, 450.06 KiB)